ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 79 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,278 | -43.2% | 38,282 | +1.9% | 0.00% | – |
| Q2 2023 | $358,090 | -0.2% | 37,575 | +15.2% | 0.00% | – |
| Q1 2023 | $358,941 | -31.4% | 32,631 | -7.7% | 0.00% | -100.0% |
| Q4 2022 | $523,491 | -22.6% | 35,371 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $675,940 | +141.4% | 35,371 | +169.5% | 0.00% | 0.0% |
| Q2 2022 | $280,000 | +35.3% | 13,125 | +22.2% | 0.00% | – |
| Q1 2022 | $207,000 | -7.2% | 10,740 | 0.0% | 0.00% | – |
| Q4 2021 | $223,000 | -13.6% | 10,740 | -0.4% | 0.00% | -100.0% |
| Q3 2021 | $258,000 | -12.2% | 10,779 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $294,000 | +7.7% | 10,779 | +14.2% | 0.00% | 0.0% |
| Q1 2021 | $273,000 | +15.2% | 9,436 | +11.9% | 0.00% | – |
| Q4 2020 | $237,000 | – | 8,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |